Idan Goren
@IBD_GorenMD
Followers
708
Following
761
Media
10
Statuses
136
Gastroenterologist | Assistant Professor Medicine| SUNY Upstate Medical University
Syracuse, NY
Joined September 2020
RT @JulsgaardMette: 🤱#Upadacitinib detectable in breast milk(n=40) Relative Infant Dose 2.7% (IQR 0.8-10.6) RID ~ #tofacitinib but ⬆️ than….
0
22
0
RT @AGA_Gastro: July's Editor's Essential Reading evaluates capsule endoscopy–guided proactive treat-to-target versus continued standard ca….
0
6
0
RT @IBD_FloMD: 🔥Congratulations to @DocCohenIBD and team 👉🏻DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS….
0
19
0
RT @IBD_FloMD: Amazing year with the @MilestoneIBD class of 2025! Congratulations to the future of #IBD. Thank you to all our faculty and s….
0
18
0
RT @AGA_Gastro: ✨ The May Editor's Essential Reading examines mechanistic implications of the #MediterraneanDiet in patients with newly dia….
0
10
0
RT @ShomronH: Still limited number, but reassuring important data on safety of Rota vaccine in bio-exposed newborns.
0
3
0
RT @h_sokol: Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative….
0
5
0
RT @ShomronH: Our RCT now in @AGA_Gastro : Pts with #Crohn in remission, who recieved treat-to-target Tx guided by #capsule endoscopy in….
0
43
0
RT @ShomronH: Fascinating data from @EranElinav lab in @CellCellPress : Metaproteomics of stool reveals 3% of content is not host nor mic….
0
3
0
RT @IBDProNews: Hey early-career GIs and #IBD folks! Our latest #REACHIBD newsletter is out now! 💖 @tinahamd, @nataliesparacio, Kaylaa' Whi….
0
3
0
RT @GMFHx: We're getting closer to the development and validation of an integrative risk score for the future risk of Crohn's disease in he….
0
7
0
RT @SaraElOualiMD: Join us today for this exciting talk and discussion with @DrRupaBanerjee1 @fatoma_kandil @CharlieMuz @JessPhilpottMD @IB….
0
2
0
RT @P_DeepakIBDMD: Safety and Effectiveness of Glucagon-like Peptide-1 receptor agonists in #IBD: our experience @WashUMedIBD @WashUMedGast….
0
11
0
RT @IBD_FloMD: 🥁 Very interesting talk by the fantastic @DrRupaBanerjee1 🥁 Please join us 👇🏽👇🏻👇🏿 @MRegueiroMD @KatieFalloonMD @SuhaAbushamm….
0
9
0
RT @JeanFredericCo1: Anti-integrin αvβ6 autoantibodies are increased in PSC patients with concomitant IBD and correlate with liver disea… h….
0
9
0
#Elderly #IBD patients w/ CDI seen as high-risk for complications. 🌍 Study: 654 patients, multicenter cohort. 📊 CDI not linked to post-discharge IBD complications/mortality up to 1 year post-discharge. @JCC_IBD @Y_ECCO_IBD @HenitYanaiMD.
0
6
25
RT @guthealthmd: Extremely important elephant in the room in clinical trial design. The rate of steroid use is much higher in patients ente….
0
8
0
RT @IBDGastroDocSg: Should steroids be used with upadacitinib during induction in UC? . - post-hoc analysis suggests not.- no impact on wee….
0
14
0
RT @JCC_IBD: Peripheral Blood #Eosinophilia at Diagnosis of #IBD Is Associated with Severe Disease Course; A Nationwide Study From the epi-….
0
7
0